(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6diazabicyclo[3.2.0]heptane benzenesulfonate

Details for Australian Patent Application No. 2005275299 (hide)

Owner Abbott Laboratories

Inventors Willcox, David R.; Mellican, Sean M.; Breting, Jeffrey M.; Wayne, Greg S.; Zhang, Geoff G.

Agent Spruson & Ferguson

Pub. Number AU-B-2005275299

PCT Pub. Number WO2006/019668

Priority 60/590,677 23.07.04 US

Filing date 8 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 22 September 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019668 Priority application(s): WO2006/019668

22 September 2011 Application Accepted

  Published as AU-B-2005275299

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275311-Process to make white oil from waxy feed using highly selective and active wax hydroisomerization catalyst

2005275286-Methods and apparatus for remotely controlling a document output device